RxSight Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	17.57	19.95	16.71	9.69	11.83	24.36
Short-Term Investments	200.31	208.18	220.52	117.49	93.97	134.97
Cash & Short-Term Investments	217.88	228.13	237.22	127.18	105.8	159.33
Cash Growth	-5.00%	-3.83%	86.52%	20.21%	-33.60%	131.00%
Accounts Receivable	22.44	23.38	30.05	20.28	10.96	4.86
Inventory	34.87	31.56	22.01	17.42	14.84	8.03
Other Current Assets	4.03	4.39	4.54	3.52	2.96	4.07
Total Current Assets	279.23	287.46	293.82	168.41	134.56	176.3
Net Property, Plant & Equipment	22.99	23.02	23.63	13.29	14.08	15.5
Other Long-Term Assets	1.78	1.34	1.11	0.86	1.53	0.93
Total Assets	303.99	311.81	318.56	182.55	150.16	192.72
Accounts Payable	7.12	5.3	4.54	3.86	2.6	1.69
Accrued Expenses	18.75	19.8	20.36	15.24	12.67	7.86
Current Portion of Leases	1.5	1.16	0.97	1.8	1.97	1.53
Total Current Liabilities	27.38	26.25	25.88	20.9	17.24	11.08
Long-Term Debt	-	-	-	-	40.17	39.76
Long-Term Leases	9.32	9.88	11.32	1.21	2.86	3.64
Other Long-Term Liabilities	-	-	0.13	0.07	-	-
Total Long-Term Liabilities	9.32	9.88	11.45	1.29	43.03	43.4
Total Liabilities	36.7	36.13	37.33	22.19	60.26	54.48
Common Stock	0.04	0.04	0.04	0.04	0.03	0
Additional Paid-in Capital	944.24	936.63	903.13	754.97	636	617.51
Accumulated Other Comprehensive Income	-0.07	0.05	0.17	-0.01	-0.1	-0.02
Retained Earnings	-676.92	-661.04	-622.1	-594.64	-546.03	-479.28
Total Common Shareholders' Equity	267.3	275.68	281.24	160.36	89.9	138.22
Shareholders' Equity	267.3	275.68	281.24	160.36	89.9	138.22
Total Liabilities & Equity	303.99	311.81	318.56	182.55	150.16	192.72
Total Debt	10.83	11.04	12.3	3.01	45	44.93
Net Cash (Debt)	207.05	217.09	224.93	124.17	60.81	114.4
Net Cash Growth	-4.62%	-3.48%	81.14%	104.20%	-46.85%	199.30%
Net Cash Per Share	5.04	5.31	5.79	3.60	2.20	8.40
Book Value	267.3	275.68	281.24	160.36	89.9	138.22
Book Value Per Share	6.51	6.75	7.24	4.65	3.25	10.14
Tangible Book Value	267.3	275.68	281.24	160.36	89.9	138.22
Tangible Book Value Per Share	6.51	6.75	7.24	4.65	3.25	10.14

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q